Increased COX-2/PGE2/EP3 signaling has long been observed in hypertensive patients and animals, and inhibition of the signaling pathway attenuates vascular remodeling in hypertension [13, 14]. This evidence concerns the gene PTGER3 and hypertensive disorder.